Kim Rosenthal

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 215 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

James Brett Case, Samantha Mackin, John M. Errico et al. · Nature Communications · 2022 · 154 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16

S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo

Bo Chen, Allison L. Miller, Marlon C. Rebelatto et al. · PLoS ONE · 2015 · 126 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action

James C. Geoghegan, Gundo Diedrich, Xiaojun Lu et al. · mAbs · 2016 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody

Vaheh Oganesyan, Peng Li, Jared S. Bee et al. · Journal of Biological Chemistry · 2018 · 72 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +14